Cambridge, UK, workshop to discuss accelerated preclinical drug development and readying molecules for Phase I
The event content will include API and formulation development, clinical study design and regulatory requirements.
The Catalent Applied Drug Delivery Institute has announced the latest in its series of educational workshops, entitled “From Discovery to Clinic: Getting Ready for Phase I,” to discuss key considerations for the rapid and efficient transitioning of molecules from discovery, through to Phase I clinical trial readiness. The event content will include API and formulation development, clinical study design and regulatory requirements, and is to be held in collaboration with One Nucleus, the international membership organization for life science and healthcare companies, at Chesterford Research Park, Little Chesterford, UK, on 20 April 2016.
The workshop starts at 9.00 a.m., and the agenda includes a presentation by Dr John Knight, head of Jkonsult Ltd., providers of expert advice on chemical and process research and development, and people development, who will discuss the key priorities in the developmental process; and Malcolm Boyce, Medical Director of Hammersmith Medicine Research, one of the largest early-phase clinical trials units in Europe, who will draw upon his experience of being involved in over 670 Phase I clinical trials and present “First-in-man studies: what we can achieve”. Also speaking will be Julien Meissonnier, Vice President, Science and Technology and Catalent Institute Board Member, who will discuss “Early dose form selection: selecting and optimizing formulation technologies for clinical success”; and Judith Jones from Catalent’s European Regulatory Affairs Department, who will present “Best Practices for preparing the IMPD quality section”.
The workshop will be the third in an ongoing series being held in European biotech research clusters. Previous events in Oxford, UK, and Copenhagen, Denmark, have brought together guest speakers including prominent academics, consultants, and technology representatives, alongside Catalent Institute and drug delivery and formulation experts. The agendas of each event have been designed to give the opportunity for biotech and life science companies to interact with industry experts and discuss some of the challenges faced by research teams within preclinical phases, to ensure drug candidates progressed to the clinic have the greatest chance of success at later stages of development.
There will also be an opportunity for companies attending the events to discuss active developmental programs in private with Catalent’s science and technology leaders.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance